Evidence map›Paper›PMID 22021617›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2011

TOX is required for development of the CD4 T cell lineage gene program.

Parinaz Aliahmad, Asha Kadavallore, Brian de la Torre, Dietmar Kappes, Jonathan Kaye

Open access · hybridAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 67 citations in OpenAlex.

  1. TOX drives CD4Nature immunology · 2026
    Article
  2. Review
  3. Dynamic Synthesis of Multi-Modal Representations for CITE-seq Data Integration and Analysis.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  4. TOX, through a glass, darkly.Frontiers in immunology · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. A novel SATB1 protein isoform with different biophysical properties.Frontiers in cell and developmental biology · 2023
    Article
  11. Cytotoxic CD4Frontiers in immunology · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. The TOX subfamily: all-round players in the immune system.Clinical and experimental immunology · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Parinaz AliahmadResearch Division of Immunology, Department of Biomedical Sciences, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Asha Kadavallore
Brian de la Torre
Dietmar Kappes
Jonathan Kaye
Cedars-Sinai Medical Center · USFox Chase Cancer Center · US

Funding

TOX, A Novel Regulator of Thymocyte SelectionR01AI054977 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI KAYE, JONATHAN G · 2004 to 2021
$6.3M
Control of Lineage Commitment in Developing ThymocytesR01CA153260 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI KAPPES, DIETMAR J · 2010 to 2014
$1.9M
NCI NIH HHS R01 CA153260NIAID NIH HHS R01 AI054977NIAID NIH HHS R01AI054977
6 · The paper itself

Abstract

The factors that regulate thymic development of the CD4(+) T cell gene program remain poorly defined. The transcriptional regulator ThPOK is a dominant factor in CD4(+) T cell development, which functions primarily to repress the CD8 lineage fate. Previously, we showed that nuclear protein TOX is also required for murine CD4(+) T cell development. In this study, we sought to investigate whether the requirement for TOX was solely due to a role in ThPOK induction. In apparent support of this proposition, ThPOK upregulation and CD8 lineage repression were compromised in the absence of TOX, and enforced ThPOK expression could restore some CD4 development. However, these "rescued" CD4 cells were defective in many aspects of the CD4(+) T cell gene program, including expression of Id2, Foxo1, and endogenous Thpok, among others. Thus, TOX is necessary to establish the CD4(+) T cell lineage gene program, independent of its influence on ThPOK expression.

Indexed as

Cell LineageAnimalsCD4-Positive T-LymphocytesCell DifferentiationCell SeparationFlow CytometryFluorescent Antibody TechniqueGene ExpressionGene Expression ProfilingGene Expression RegulationHomeodomain ProteinsLymphocyte ActivationMiceMice, TransgenicReal-Time Polymerase Chain ReactionTranscription FactorsHomeodomain ProteinsRhox8 protein, mouseTranscription FactorsZbtb7b protein, mouse

Identifiers

PMID22021617
PMCPMC3221881
OpenAlexW2114892147

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.